EDWARDS JAMES MICHAEL enters BIOAFFINITY TECHNOLOGIES, INC. with 13.96K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 9/20/2024ACC: 0001493152-24-037640
Officer· Chief Financial Officer
Since Aug 2022
13.96K
Baseline shares
100% direct
13.96K
Direct ownership
1 position
14.66K
Derivative underlying
4 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock, par value $0.007
DirectShares owned13.96K
Total
13.96K direct13.96K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, par value $0.007 | 13.96K | Direct |
| Total | 13.96K | 13.96K direct |
Derivative Holdings4
Non-tradeable Warrants (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
6.12K
Shares owned
N/A
Exercise price
3.0625
Expiration
—
Exercise window
—
Warrant (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
1.90K
Shares owned
N/A
Exercise price
5.25
Expiration
—
Exercise window
—
Warrant (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
761.00
Shares owned
N/A
Exercise price
5.25
Expiration
—
Exercise window
—
Warrants (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
5.88K
Shares owned
N/A
Exercise price
3.0625
Expiration
—
Exercise window
—
Total
Underlying
14.66K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Non-tradeable Warrants (right to buy) Direct | Common Stock | 3.0625 | — | — | 6.12K | N/A |
| Warrant (right to buy) Direct | Common Stock | 5.25 | — | — | 1.90K | N/A |
| Warrant (right to buy) Direct | Common Stock | 5.25 | — | — | 761.00 | N/A |
| Warrants (right to buy) Direct | Common Stock | 3.0625 | — | — | 5.88K | N/A |
| Total | 14.66K | 0.00 | ||||